D-0660-2026 Class II Ongoing
FDA drug recall D-0660-2026 was initiated by Lannett Company Inc. on Jun 26, 2026 and is designated Class II. Reason for recall: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. The recall status is ongoing. Affected quantity: 1392 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2026
- Initiation Date
- Jun 26, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1392 bottles
Product description
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
Reason for recall
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Distribution pattern
US Nationwide.
Code information
Lot#: 25285401A, Exp. Date: 04/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0660-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026